SLC2A3 and neoplasm: As the crucial role of the myeloid compartment in the tumor microenvironment has emerged and gained increasing importance, how GLUT3 expression and GLUT3-targeted therapy affect tumor progression and immunotherapy outcome may be clinically relevant.